Dudediligence.

Spyre Therapeutics, Inc

SYRENASDAQ · Pharmaceutical Preparations
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Oct 5424B5Prospectus for an offering
  2. Oct 113GPassive stake of 5% or more (13G), filed by Paradigm Biocapital Advisors
  3. Sep 88-KRegulation FD disclosure and other events7.018.019.01
  4. Aug 258-KRegulation FD disclosure and other events7.018.019.01
  5. Aug 48-KResults of operations2.029.01
  6. Aug 410-QQuarterly report
  7. Jun 158-KRegulation FD disclosure and other events7.018.019.01
  8. Jun 18-KOther events8.019.01
  9. May 298-KOfficer or director change and shareholder vote5.025.079.01
  10. May 58-KResults of operations2.029.01
  11. May 510-QQuarterly report
  12. Apr 168-KMaterial agreement1.019.01
  13. Apr 15424B5Prospectus for an offering
  14. Apr 13424B5Prospectus for an offering
  15. Apr 138-KResults of operations and other events2.028.01
  16. Apr 138-KRegulation FD disclosure and other events7.018.019.01
  17. Feb 19S-3Shelf registration
  18. Feb 198-KResults of operations2.029.01
  19. Feb 1910-KAnnual report
  20. Jan 128-KRegulation FD disclosure7.019.01
  21. Nov 4, 20258-KResults of operations and Regulation FD disclosure2.027.018.019.01
  22. Nov 4, 202510-QQuarterly report
  23. Oct 15, 20258-KMaterial agreement1.019.01
  24. Oct 14, 2025424B5Prospectus for an offering
  25. Oct 14, 2025424B5Prospectus for an offering
  26. Oct 14, 20258-KResults of operations2.02
  27. Aug 5, 20258-KResults of operations2.029.01
  28. Aug 5, 202510-QQuarterly report
  29. Jun 17, 20258-KRegulation FD disclosure and other events7.018.019.01
  30. Jun 2, 20258-KShareholder vote5.079.01
  31. May 8, 20258-KResults of operations2.029.01
  32. May 8, 202510-QQuarterly report
  33. Mar 6, 20258-KChange of auditor4.019.01
  34. Feb 27, 2025S-3Shelf registration